Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...

This supplement offers an 1800mg Keto blocker solution, which enhances the Keto diet's results for those on the plan or just starting out.

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

A holistic approach that considers both physical and psychological aspects can help achieve and maintain a healthy weight ...

Life Time Group Holdings is best-known for its fitness clubs, but executives see plenty of room to grow in the field of ...

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Natural fat burners have gained popularity among those looking to shed extra pounds. Many people want to know if there are ...

In a world where weight management is increasingly prioritized, appetite suppressants have gained immense popularity for ...

Dr. Jonathan Kaplan, a board-certified plastic surgeon from San Francisco, has amassed 1.6 million views on TikTok (@ realdrbae) with his warning: "Once you stop Ozempic, you will regain the weight." ...

Ketogenic diets show promise in affecting menstrual physiology, with increased cycle frequency and intensity observed in pre-menopausal women with obesity.

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...